New York - Federal lawmakers have released excerpts from thousands of documents detailing how two drugmakers hiked prices to squeeze more money from some life-saving medicines, a practice that has sparked public outrage.

A congressional review of more than 300,000 pages from Turing Pharmaceuticals and Valeant Pharmaceuticals reveals how executives planned to maximize profits from drugs used to treat patients with heart problems and other conditions including AIDS and cancer.

Rep. Elijah Cummings, D-Maryland, released the information Tuesday ahead of a hearing Thursday to examine exorbitant price spikes. Cummings has used his position atop the House Committee on Oversight and Government Reform to investigate several companies that have bought previously low-cost drugs and jacked up their prices many times over.

The Democrat said in a statement that the documents show “that many drug companies are lining their pockets at the expense of some of the most vulnerable families in our nation.”... Read More: VIN